Management and Treatment of Tumor Lysis Syndrome leaf node


URI

https://openalex.org/T12845

Label

Management and Treatment of Tumor Lysis Syndrome

Description

This cluster of papers focuses on the management, treatment, and complications of tumor lysis syndrome (TLS), a potentially life-threatening oncologic emergency characterized by metabolic disturbances. The papers cover various aspects including therapeutic strategies, classification, prophylaxis, risk evaluation, and the use of medications such as rasburicase and dapsone. Additionally, the cluster discusses related conditions like methemoglobinemia and hyperuricemia, particularly in pediatric and adult patients undergoing chemotherapy for hematologic malignancies.

Implementation

@prefix oasubfields: <https://openalex.org/subfields/> .
@prefix openalex: <https://lambdamusic.github.io/openalex-hacks/ontology/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://openalex.org/T12845> a skos:Concept ;
    rdfs:label "Management and Treatment of Tumor Lysis Syndrome"@en ;
    rdfs:isDefinedBy openalex: ;
    owl:sameAs <https://en.wikipedia.org/wiki/Tumor_lysis_syndrome>,
        <https://openalex.org/T12845> ;
    skos:broader oasubfields:2740 ;
    skos:definition "This cluster of papers focuses on the management, treatment, and complications of tumor lysis syndrome (TLS), a potentially life-threatening oncologic emergency characterized by metabolic disturbances. The papers cover various aspects including therapeutic strategies, classification, prophylaxis, risk evaluation, and the use of medications such as rasburicase and dapsone. Additionally, the cluster discusses related conditions like methemoglobinemia and hyperuricemia, particularly in pediatric and adult patients undergoing chemotherapy for hematologic malignancies."@en ;
    skos:inScheme openalex: ;
    skos:prefLabel "Management and Treatment of Tumor Lysis Syndrome"@en ;
    openalex:cited_by_count 90944 ;
    openalex:works_count 10495 .